Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition

Clinical Science

Volumn 118, Issue 4, 2010, Pages 269-279

  Velskoska, Elena ^a   Dean, Rachael G ^a   Burchill, Luke ^a   Levidiotis, Vicki ^b   Burrell, Louise M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WESTERN HOSPITAL   (Australia)

Author keywords

Angiotensin (1 7); Kidney; Mas receptor; Renal injury; Renin angiotensin system (RAS)

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CREATINE; MESSENGER RNA; PROTEIN MAS; RAMIPRIL; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; GENE EXPRESSION; HYPERTENSION; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY MEDULLA; NONHUMAN; POLYURIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; FEMALE; GENE EXPRESSION; HYPERTENSION; KIDNEY; NEPHRECTOMY; PEPTIDYL-DIPEPTIDASE A; POLYURIA; PROTEINURIA; PROTO-ONCOGENE PROTEINS; RAMIPRIL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 70549098001     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090318     Document Type: Article

References (47)

1. Cooper, M. E. and Johnston, C. I. (2000) Optimizing treatment of hypertension in patients with diabetes. JAMA, J. Am. Med. Assoc. 283, 3177-3179
2. Velez, J. C. (2008) The importance of the intrarenal renin-angiotensin system. Nat. Clin. Pract. Nephrol. 2, 89-100
3. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R. et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9
4. Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G. and Turner, A. J. (2000) A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243
5. Burrell, L. M., Johnston, C. I., Tikellis, C. and Cooper, M. E. (2004) ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol. Metab. 15, 166-169
6. Ferrario, C. M. (2006) Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 47, 515-521
7. Tallant, E. A. and Clark, M. A. (2003) Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 42, 574-579
8. Santos, R. A., Simoes e Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V., Lopes, M. T., Bader, M. et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263
9. Ye, M., Wysocki, J., William, J., Soler, M. J., Cokic, I. and Batlle, D. (2006) Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 17, 3067-3075
10. Soler, M. J., Ye, M., Wysocki, J., William, J., Lloveras, J. and Batlle, D. (2009) Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan. Am. J. Physiol. Renal Physiol. 296, F398-F405
11. Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J. and Cooper, M. E. (2003) Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41, 392-397
12. Li, N., Zimpelmann, J., Cheng, K., Wilkins, J. A. and Burns, K. D. (2005) The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am. J. Physiol. Renal Physiol. 288, F353-F362
13. Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., Cooper, M. E. and Johnston, C. I. (2005) Myocardial infarction increases ACE2 expression in rat and humans. Eur. Heart J. 26, 369-375
14. Reich, H. N., Oudit, G. Y., Penninger, J. M., Scholey, J. W. and Herzenberg, A. M. (2008) Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 74, 1610-1616
15. Dean, R. G. and Burrell, L. M. (2007) ACE2 and diabetic complications. Curr. Pharm. Des. 13, 2730-2735
16. Batlle, D., Soler, M. J. and Wysocki, J. (2008) New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2: a potential target for treatment of hypertension and diabetic nephropathy. Curr. Opin. Nephrol. Hypertens 17, 250-257
17. Oudit, G. Y., Herzenberg, A. M., Kassiri, Z., Wong, D., Reich, H., Khokha, R., Crackower, M. A., Backx, P. H., Penninger, J. M. and Scholey, J. W. (2006) Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am. J. Pathol. 168, 1808-1820
18. Soler, M. J., Wysocki, J., Ye, M., Lloveras, J., Kanwar, Y. and Batlle, D. (2007) ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 72, 614-623
19. Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M. and Scholey, J. W. (2007) Loss of angiotensin-converting enzyme-2 (ACE2) accelerates diabetic kidney injury. Am. J. Pathol. 171, 438-451
20. Cao, Z., Burrell, L. M., Tikkanen, I., Bonnet, F., Cooper, M. E. and Gilbert, R. E. (2001) Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomised rats. Kidney Int. 60, 715-721
21. Cao, Z. and Cooper, M. E. (2001) Role of angiotensin II in tubulointerstitial injury. Semin. Nephrol. 21, 554-562
22. Taal, M. W. and Brenner, B. M. (2008) Adaptation to nephron loss. 2008. The Kidney (Brenner, B. M. and Rector, F. C., eds.), pp. 783-819, Saunders, Philadelphia
23. Burchill, L., Velkoska, E., Dean, R. G., Lew, R. A., Smith, A. I., Levidiotis, V. and Burrell, L. M. (2008) Acute kidney injury in the rat causes cardiac remodelling and increases ACE2 expression. Exp. Physiol. 93, 622-630
24. a Velkoska, E., Dean, R. G., Burchill, L. J. and Burrell, L. M. (2009) Role for renal angiotensin converting enzyme 2 in the adaption to nephron loss following subtotal nephrectomy in the rat. Hypertension 53, 1105
25. Herath, C. B., Warner, F. J., Lubel, J. S., Dean, R. G., Jia, Z., Lew, R. A., Smith, A. I., Burrell, L. M. and Angus, P. W. (2007) Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J. Hepatol. 47, 387-395
26. Farina, N. K., Johnston, C. I. and Burrell, L. M. (2000) Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs. J. Hypertens. 18, 749-755
27. Lew, R. A., Warner, F. J., Hanchapola, I., Yarski, M. A., Manohar, J., Burrell, L. M. and Smith, A. I. (2008) Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp. Physiol. 93, 685-693
28. Case, D. B., Atlas, S. A., Mouradian, J. A., Fishman, R. A., Sherman, R. L. and Laragh, J. H. (1980) Proteinuria during long-term captopril therapy. JAMA, J. Am. Med. Assoc. 244, 346-349
29. 125I-labelled MK351A. Clin. Exp. Pharmacol. Physiol. 11, 431-435
30. Pinheiro, S. V., Ferreira, A. J., Kitten, G. T., da Silveira, K. D., da Silva, D. A., Santos, S. H., Gava, E., Castro, C. H., Magalhaes, J. A., da Mota, R. K. et al. (2009) Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney Int. 75, 1184-1193
31. Ferrario, C. M., Jessup, J., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Ann Tallant, E., Smith, R. D. and Chappell, M. C. (2005) Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int. 68, 2189-2196
32. Yamada, K., Iyer, S. N., Chappell, M. C., Ganten, D. and Ferrario, C. M. (1998) Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 32, 496-502
33. Wysocki, J., Ye, M., Soler, M. J., Gurley, S. B., Xiao, H. D., Bernstein, K. E., Coffman, T. M., Chen, S. and Batlle, D. (2006) ACE and ACE2 activity in diabetic mice. Diabetes 55, 2132-2139
34. Ye, M., Wysocki, J., Naaz, P., Salabat, M. R., LaPointe, M. S. and Batlle, D. (2004) Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoproptective combination? Hypertension 43, 1120-1125
35. Navar, L. G., Inscho, E. W., Majid, S. A., Imig, J. D., Harrison-Bernard, L. M. and Mitchell, K. D. (1996) Paracrine regulation of the renal microcirculation. Physiol. Rev. 76, 425-536
36. Cowley, Jr, A. W., Mattson, D. L., Lu, S. and Roman, R. J. (1995) The renal medulla and hypertension. Hypertension 25, 663-673
37. Chou, S. Y., Porush, J. G. and Faubert, P. F. (1990) Renal medullary circulation: hormonal control. Kidney Int. 37, 1-13
38. Magaldi, A. J., Cesar, K. R., de Araujo, M., Simoes e Silva, A. C. and Santos, R. A. (2003) Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors. Pflugers Arch. 447, 223-230
39. Santos, R. A. and Baracho, N. C. (1992) Angiotensin-(1-7) is a potent antidiuretic peptide in rats. Braz. J. Med. Biol. Res. 25, 651-654
40. Santos, R. A., Simoes e Silva, A. C., Magaldi, A. J., Khosla, M. C., Cesar, K. R., Passaglio, K. T. and Baracho, N. C. (1996) Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension 27, 875-884
41. Simoes e Silva, A. C., Bello, A. P., Baracho, N. C., Khosla, M. C. and Santos, R. A. (1998) Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1-7) antagonist in normotensive and hypertensive rats. Regul. Pept. 74, 177-184
42. Ferreira, A. J., Pinheiro, S. V., Castro, C. H., Silva, G. A., Silva, A. C., Almeida, A. P., Bader, M., Rentzsch, B., Reudelhuber, T. L. and Santos, R. A. (2006) Renal function in transgenic rats expressing an angiotensin-(1-7)-producing fusion protein. Regul. Pept. 137, 128-133
43. Rice, G. I., Thomas, D. A., Grant, P. J., Turner, A. J. and Hooper, N. M. (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 383, 45-51
44. Lely, A. T., Hamming, I., van Goor, H. and Navis, G. J. (2004) Renal ACE2 expression in human kidney disease. J. Pathol. 204, 587-593
45. Mizuiri, S., Hemmi, H., Arita, M., Ohashi, Y., Tanaka, Y., Miyagi, M., Sakai, K., Ishikawa, Y., Shibuya, K., Hase, H. and Aikawa, A. (2008) Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am. J. Kidney. Dis. 51, 613-623
46. Konoshita, T., Wakahara, S., Mizuno, S., Motomura, M., Aoyama, C., Makino, Y., Kawai, Y., Kato, N., Koni, I., Miyamori, I. and Mabuchi, H. (2006) Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care 29, 848-852
47. Hernandez Prada, J. A., Ferreira, A. J., Katovich, M. J., Shenoy, V., Qi, Y., Santos, R. A., Castellano, R. K., Lampkins, A. J., Gubala, V., Ostrov, D. A. and Raizada, M. K. (2008) Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension 51, 1312-1317